Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 2/20 | 0.47 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | PGK1 | P00558 | 1/20 | 0.37 |
| ▸ | KDM4A | O75164 | 2/20 | 0.36 |
| ▸ | KDM5A | P29375 | 2/20 | 0.36 |
| ▸ | GRIA1 | P42261 | 3/20 | 0.36 |
| ▸ | CACNG8 | Q8WXS5 | 3/20 | 0.36 |
| ▸ | KMO | O15229 | 2/20 | 0.35 |
| ▸ | SLC22A12 | Q96S37 | 2/20 | 0.35 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.35 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | SLC1A5 | Q15758 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2088614 | 0.84 | KMO (0.44) | NOTUMPGK1KMOGRIN2BEPHX2 | |
| SCHEMBL3026636 | 0.81 | EPHX2 (0.41) | KMOEPHX2SLC1A5 | |
| SCHEMBL8462016 | 0.78 | NOTUM (0.44) | NOTUMPDE3AEPHX1PGK1GRIA1 | |
| SCHEMBL11910291 | 0.76 | MAPT (0.46) | NOTUMPDE3AEPHX1PGK1SLC1A5 | |
| SCHEMBL20309113 | 0.76 | NOTUM (0.43) | NOTUMPDE3AEPHX1PGK1KDM4A | |
| SCHEMBL1416864 | 0.76 | NOTUM (0.43) | NOTUMPDE3AEPHX1PGK1KDM4A | |
| SCHEMBL10933173 | 0.76 | NOTUM (0.43) | NOTUMPDE3A | |
| SCHEMBL363418 | 0.76 | HSD17B10 (0.46) | NOTUMPDE3AEPHX1PGK1KDM4A | |
| SCHEMBL1555931 | 0.76 | CYP3A4 (0.46) | NOTUMPDE3AEPHX1PGK1KDM4A | |
| SCHEMBL15568786 | 0.76 | NOTUM (0.43) | NOTUMPDE3AEPHX1PGK1KDM4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8426631-B2 | Fungicidal compounds, method for the production thereof, and use thereof to combat damaging fungi, and agents comprising the same | BASF SE (DE) | 2013-04-23 | — | — | US | disclosed |
| US-20100304966-A1 | Fungicidal Compounds, Method For the Production Thereof, And Use Thereof To Combat Damaging Fungi, And Agents Comprising The Same | BASF SE (DE) | 2010-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100304966-A1 | Fungicidal Compounds, Method For the Production Thereof, And Use Thereof To Combat Damaging Fungi, And Agents Comprising The Same | CYP51A1, ERG28, CAT | NOTUM 204/4885PDE3A 218/4885EPHX1 1572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.